Endovascular Treatment for eXtra-Large Ischemic Stroke (XL STROKE-2)
Efficacy and Safety of Endovascular Thrombectomy Plus Medical Management Versus Medical Management Alone in Acute Ischemic Stroke Patients With Large Vessel Occlusion and Extra-Large Infarct Core: A Multicenter, Randomized Controlled Trial
Sponsor: Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Listed as NCT06388148, this NA trial focuses on Stroke, Acute Ischemic and remains actively recruiting participants. Sponsored by Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, it has been updated 6 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Recruiting NA
-
Nov 2024 — Jan 2026 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
May 2024 — Jun 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
- Longyan First Affiliated Hospital of Fujian Medical University
- Taizhou First People's Hospital
- The First Affiliated Hospital, University of South China
- Xiangtan Central Hospital
- Zhangzhou Affiliated Hospital of Fujian Medical University
- Zhongming Qiu
For direct contact, visit the study record on ClinicalTrials.gov .